Metformin: all 1,377 studies that test it

Page 11 of 14. Open to participants first (169), then studies with results posted, then the rest; newest registration first within each.

• Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With RadiotherapyStatus unknownNCT02149459Phase 1
• Study of Dabrafenib, Trametinib and Metformin for Melanoma PatientsWithdrawnNCT02143050Phase 1/2
• Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the ElderlyCompletedNCT02125305Phase 1
• Advanced Lung Cancer Treatment With Metformin and Chemo-RadiotherapyTerminatedNCT02115464Phase 2
• Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male SubjectsCompletedNCT02109679Phase 1
• Oral Antidiabetic Agents in PregnancyStatus unknownNCT02091336Phase 4
• A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male SubjectsCompletedNCT02088918Phase 1
• Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticSActive, not recruitingNCT02087826Not applicable
• Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)CompletedNCT02086526Phase 1
• Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic UncouplingCompletedNCT02083692Early Phase 1
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02073227Phase 1
• The Hypotensive Effect of Metformin in Hypertensive Patients.Status unknownNCT02072382Phase 4
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCompletedNCT02071368Phase 1
• A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02065752Phase 1
• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.CompletedNCT02056600Phase 1
• The Role of Metformin and Colesevelam in Human GLP-1 SecretionCompletedNCT02050074Phase 4
• Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
• Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic PeriodontitisStatus unknownNCT02048761Phase 2
• Insulin Clamp Ancillary Study for Assessment of Insulin ResistanceCompletedNCT02045290Phase 3
• Endometrial Cancer Biomarker Changes Following Exposure to MetforminWithdrawnNCT02042495Phase 2
• Metformin for Brain Repair in Children With Cranial-Spinal Radiation for MedulloblastomaCompletedNCT02040376Phase 3
• fMRI and Ghlrein in Obesity and Binge Eating DisorderCompletedNCT02038712Not applicable
• PDE-4 Inhibitor Roflumilast and Polycystic Ovary SyndromeCompletedNCT02037672Phase 4
• Metformin and Furosemide Drug-Drug Interaction StudyCompletedNCT02028689Phase 1
• Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor TherapyCompletedNCT02027753Phase 4
• Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes PatientsCompletedNCT02027103Not applicable
• Vaginal Administration of Metformin in PCOS Patients.Status unknownNCT02026869Early Phase 1
• Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy SubjectsCompletedNCT02022254Phase 1
• L-citrulline and Metformin in Becker's Muscular DystrophyCompletedNCT02018731Phase 2
• Metformin in the Diastolic Dysfunction of Metabolic SyndromeCompletedNCT02017561Phase 2
• Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02005419Phase 2
• PCOS Treatment Using DLBS3233, Metformin, and Combination of BothCompletedNCT01999686Phase 3
• Metformin in Stage IV Lung AdenocarcinomaTerminatedNCT01997775Phase 2
• Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
• Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and MetforminCompletedNCT01992211Phase 1
• A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni SyndromeCompletedNCT01981525Phase 1
• Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast CancerCompletedNCT01980823Early Phase 1
• Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.CompletedNCT01971034Phase 2
• Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT01969318Phase 2
• Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes PatientsCompletedNCT01963663Not applicable
• Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.CompletedNCT01956929Phase 1
• Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryWithdrawnNCT01954732Phase 1
• Metformin and 5-fluorouracil for Refractory Colorectal Cancer.CompletedNCT01941953Phase 2
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01941199Phase 1
• Metformin Plus Irinotecan for Refractory Colorectal CancerStatus unknownNCT01930864Phase 2
• NeoMET Study in Neoadjuvant Treatment of Breast CancerTerminatedNCT01929811Phase 2
• A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal CancerTerminatedNCT01926769Phase 2
• Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With PregnancyCompletedNCT01915550Phase 3
• Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on MetforminCompletedNCT01911468Phase 4
• Preoperative Window Study of Metformin for the Treatment of Endometrial CancerCompletedNCT01911247Early Phase 1
• Cardiovascular Effects of Metformin on ObesityWithdrawnNCT01910246Phase 4
• Triple Therapy in Type 2 Diabetic PatientsStatus unknownNCT01895569Phase 4
• Incretin Effect in PCOS WomenCompletedNCT01892254Phase 4
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4
• Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mgCompletedNCT01885520Phase 1
• Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer PatientsCompletedNCT01885013Phase 2
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of MetforminCompletedNCT01884558Phase 1
• Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart DiseaseCompletedNCT01879293Phase 4
• Bioequivalence StudyCompletedNCT01874080Phase 1
• Study of Metformin Pharmacogenetics in TwinsCompletedNCT01869621Phase 1
• Combination of Metformin With Gefitinib to Treat NSCLCCompletedNCT01864681Phase 2
• The Metformin Active Surveillance Trial (MAST) StudyActive, not recruitingNCT01864096Phase 3
• Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of MetforminCompletedNCT01857609Phase 1
• Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing CountryStatus unknownNCT01855763Phase 2/3
• Pilot Study Evaluating the Efficacy and Safety of Metformin in MelanomaCompletedNCT01840007Phase 2
• An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to MetforminTerminatedNCT01816659Phase 1
• The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent ClaudicationTerminatedNCT01799057Phase 4
• PCOS, Therapy and Markers of Cardiovascular RiskStatus unknownNCT01798875Phase 4
• Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate CancerCompletedNCT01796028Phase 2
• Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast CancerCompletedNCT01793948Early Phase 1
• Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary SyndromeCompletedNCT01791647Not applicable
• Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dCompletedNCT01787396Phase 3
• Metformin for Treatment of Antipsychotic-induced DyslipidemiaCompletedNCT01778244Phase 4
• Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin CalciumCompletedNCT01775579Phase 1
• Metformin and Longevity Genes in PrediabetesCompletedNCT01765946Phase 4
• A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy VolunteersCompletedNCT01756417Phase 1
• Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese WomenTerminatedNCT01756105Phase 2
• A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-AdministrationCompletedNCT01755494Phase 1
• Prostate Cancer Active Surveillance Metformin TrialWithdrawnNCT01733836Phase 2
• Bioequivalence Study for Acarbose / Metformin FDCCompletedNCT01728740Phase 1
• Interaction Between St John's Wort and Metformin?CompletedNCT01726764Phase 1
• The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled StudyCompletedNCT01725490Phase 2
• A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy ParticipantsCompletedNCT01719614Phase 1
• Effectiveness of Metformin in Recurrent Miscarriage in a Woman With HyperinsulinaemiaWithdrawnNCT01718340Phase 4
• A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 DiabetesCompletedNCT01718093Phase 4
• Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian SyndromeCompletedNCT01693289Phase 1
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedNCT01691846Phase 3
• Improving the Treatment for Women With Early Stage Cancer of the UterusActive, not recruitingNCT01686126Phase 2
• Metformin for the Treatment of Endometrial HyperplasiaCompletedNCT01685762Early Phase 1
• Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African AmericansCompletedNCT01681693Phase 1
• Obesity in Children and Adolescents: Associated Risks and Early InterventionCompletedNCT01677923Phase 3
• Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer PatientsCompletedNCT01677897Phase 2
• Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican WomenCompletedNCT01675310Phase 4
• Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and MetforminTerminatedNCT01666665Phase 2/3
• Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin ResistanceStatus unknownNCT01664845Phase 2/3
• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered AloneCompletedNCT01662674Phase 1
• Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedNCT01658501Phase 2
• The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretionCompletedNCT01656057Not applicable
• The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking ClozapineTerminatedNCT01654640Phase 4
• Study of Erlotinib and Metformin in Triple Negative Breast CancerCompletedNCT01650506Phase 1

← Metformin overview